IVI and Bharat Biotech jointly launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica https://ift.tt/eA8V8J

The commencement of phase-II/III study of BBV87 in Costa Rica is a milestone and a first step towards developing a promising vaccine candidate against Chikungunya, an exhausting disease.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3jf0Ngt
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.